Lightening the viral load to lessen covid-19 severity.
作者信息
Burgess Stephen, Smith David, Kenyon Julia C, Gill Dipender
机构信息
MRC Biostatistics Unit, School of Clinical Medicine, University of Cambridge, Cambridge, UK
Institute for Infection and Immunity, St George's, University of London, London, UK.
出版信息
BMJ. 2020 Dec 10;371:m4763. doi: 10.1136/bmj.m4763.
Abstract
摘要
相似文献
1
Lightening the viral load to lessen covid-19 severity.减轻病毒载量以降低新冠病毒肺炎的严重程度。
BMJ. 2020 Dec 10;371:m4763. doi: 10.1136/bmj.m4763.
2
SARS-CoV-2 pandemic: An overview.2019冠状病毒病大流行概述。
Adv Biol Regul. 2020 Aug;77:100736. doi: 10.1016/j.jbior.2020.100736. Epub 2020 Jun 17.
3
Importance of sustaining non-pharmaceutical interventions for COVID-19 until herd immunity.在实现群体免疫之前持续实施针对新冠病毒的非药物干预措施的重要性。
Hong Kong Med J. 2021 Apr;27(2):95-96. doi: 10.12809/hkmj215112.
4
COVID-19: Why Has the Mortality Rate Declined?新型冠状病毒肺炎：死亡率为何下降？
J Psychiatr Pract. 2020 Sep;26(5):394-399. doi: 10.1097/PRA.0000000000000494.
5
A "No More Waves" strategy for COVID-19 in Canada.加拿大针对新冠疫情的“不再有浪潮”策略。
CMAJ. 2021 Jan 25;193(4):E132-E134. doi: 10.1503/cmaj.202685. Epub 2020 Dec 9.
6
Covid-19 has redefined airborne transmission.新冠疫情重新定义了空气传播。
BMJ. 2021 Apr 14;373:n913. doi: 10.1136/bmj.n913.
7
Algeria's response to COVID-19: an ongoing journey.阿尔及利亚对新冠疫情的应对：一段仍在持续的历程。
Lancet Respir Med. 2021 May;9(5):449. doi: 10.1016/S2213-2600(21)00083-7. Epub 2021 Feb 8.
8
Weathering COVID-19 storm: Successful control measures of five Asian countries.应对新冠疫情风暴：五个亚洲国家成功的防控措施。
Am J Infect Control. 2020 Jul;48(7):851-852. doi: 10.1016/j.ajic.2020.04.021. Epub 2020 Apr 29.
9
COVID-19 and mental health challenges in Pakistan.巴基斯坦的新冠疫情与心理健康挑战
Int J Soc Psychiatry. 2021 May;67(3):303-304. doi: 10.1177/0020764020954487. Epub 2020 Sep 9.
10
[Covid-19, september 2020: fall storm warning].[2020年9月，新冠疫情：秋季风暴预警]
Virologie (Montrouge). 2020 Dec 1;24(6):361-367. doi: 10.1684/vir.2020.0865.
引用本文的文献
1
Soluble wild-type ACE2 molecules inhibit newer SARS-CoV-2 variants and are a potential antiviral strategy to mitigate disease severity in COVID-19.可溶性野生型 ACE2 分子可抑制新型 SARS-CoV-2 变体，是减轻 COVID-19 疾病严重程度的一种潜在抗病毒策略。
Clin Exp Immunol. 2023 Dec 13;214(3):289-295. doi: 10.1093/cei/uxad096.
2
Immune Cell Response during COVID-19 Infection and following SARS-CoV-2 Vaccination in Patients Admitted to Intensive Care Unit.COVID-19 感染期间和接种 SARS-CoV-2 疫苗后入住重症监护病房患者的免疫细胞反应。
J Immunol Res. 2023 Apr 24;2023:4059484. doi: 10.1155/2023/4059484. eCollection 2023.
3
A large-scale machine learning study of sociodemographic factors contributing to COVID-19 severity.一项关于导致新冠病毒疾病严重程度的社会人口学因素的大规模机器学习研究。
Front Big Data. 2023 Mar 24;6:1038283. doi: 10.3389/fdata.2023.1038283. eCollection 2023.
4
Adjudicated myocarditis and multisystem illness trajectory in healthcare workers post-COVID-19.COVID-19 后医护人员裁定的心肌炎和多系统疾病进程。
Open Heart. 2023 Feb;10(1). doi: 10.1136/openhrt-2022-002192.
5
Selective IgA Deficiency May Be an Underrecognized Risk Factor for Severe COVID-19.选择性 IgA 缺乏可能是严重 COVID-19 的一个未被充分认识的危险因素。
J Allergy Clin Immunol Pract. 2023 Jan;11(1):181-186. doi: 10.1016/j.jaip.2022.10.002. Epub 2022 Oct 12.
6
Predictors of adverse outcome in the first and second waves of the COVID-19 pandemic: results from a UK centre.新冠疫情第一波和第二波中不良结局的预测因素：来自英国一家中心的结果
Ther Adv Infect Dis. 2022 Jan 30;9:20499361221074569. doi: 10.1177/20499361221074569. eCollection 2022 Jan-Dec.
7
Nationwide Social Distancing and the Epidemiology of Severe Acute Respiratory Infections.全国范围的社会隔离与严重急性呼吸道感染的流行病学。
Yonsei Med J. 2021 Oct;62(10):954-957. doi: 10.3349/ymj.2021.62.10.954.
8
Can Comorbidity Data Explain Cross-State and Cross-National Difference in COVID-19 Death Rates?合并症数据能否解释新冠病毒疾病死亡率的州际和跨国差异？
Risk Manag Healthc Policy. 2021 Jul 7;14:2877-2885. doi: 10.2147/RMHP.S313312. eCollection 2021.
9
Difference in mortality among individuals admitted to hospital with COVID-19 during the first and second waves in South Africa: a cohort study.南非第一波和第二波期间因 COVID-19 住院的个体的死亡率差异：一项队列研究。
Lancet Glob Health. 2021 Sep;9(9):e1216-e1225. doi: 10.1016/S2214-109X(21)00289-8. Epub 2021 Jul 9.
10
Common Variable Immunodeficiency Disorders, T-Cell Responses to SARS-CoV-2 Vaccines, and the Risk of Chronic COVID-19.常见变异性免疫缺陷病、T 细胞对 SARS-CoV-2 疫苗的反应与慢性 COVID-19 的风险。
J Allergy Clin Immunol Pract. 2021 Oct;9(10):3575-3583. doi: 10.1016/j.jaip.2021.06.019. Epub 2021 Jun 25.
本文引用的文献
1
Infection fatality risk for SARS-CoV-2 in community dwelling population of Spain: nationwide seroepidemiological study.西班牙社区居住人群中 SARS-CoV-2 的感染病死率：全国血清流行病学研究。
BMJ. 2020 Nov 27;371:m4509. doi: 10.1136/bmj.m4509.
2
Improving Survival of Critical Care Patients With Coronavirus Disease 2019 in England: A National Cohort Study, March to June 2020.改善 2019 年冠状病毒病危重症患者的生存：2020 年 3 月至 6 月的全国队列研究。
Crit Care Med. 2021 Feb 1;49(2):209-214. doi: 10.1097/CCM.0000000000004747.
3
The changing demographics of COVID-19.新冠病毒病不断变化的人口统计学特征。
Lancet Respir Med. 2020 Dec;8(12):e95. doi: 10.1016/S2213-2600(20)30461-6. Epub 2020 Oct 6.
4
Impact of lockdown on Covid-19 case fatality rate and viral mutations spread in 7 countries in Europe and North America.封锁对欧洲和北美 7 个国家的新冠病毒病死率和病毒突变传播的影响。
J Transl Med. 2020 Sep 2;18(1):338. doi: 10.1186/s12967-020-02501-x.
5
Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta-analysis.COVID-19 重症患者全身使用皮质类固醇与死亡率的关联：一项荟萃分析。
JAMA. 2020 Oct 6;324(13):1330-1341. doi: 10.1001/jama.2020.17023.
6
Airborne transmission of covid-19.新型冠状病毒肺炎的空气传播
BMJ. 2020 Aug 20;370:m3206. doi: 10.1136/bmj.m3206.
7
Masks Do More Than Protect Others During COVID-19: Reducing the Inoculum of SARS-CoV-2 to Protect the Wearer.口罩在 COVID-19 期间不仅能保护他人：减少 SARS-CoV-2 的接种量以保护佩戴者。
J Gen Intern Med. 2020 Oct;35(10):3063-3066. doi: 10.1007/s11606-020-06067-8. Epub 2020 Jul 31.
8
Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development.叙利亚仓鼠作为 SARS-CoV-2 感染及对策研发的小动物模型。
Proc Natl Acad Sci U S A. 2020 Jul 14;117(28):16587-16595. doi: 10.1073/pnas.2009799117. Epub 2020 Jun 22.
9
Inoculum at the time of SARS-CoV-2 exposure and risk of disease severity.接种疫苗时间与 SARS-CoV-2 暴露和疾病严重程度风险。
Int J Infect Dis. 2020 Aug;97:290-292. doi: 10.1016/j.ijid.2020.06.035. Epub 2020 Jun 14.
10
Surgical Mask Partition Reduces the Risk of Noncontact Transmission in a Golden Syrian Hamster Model for Coronavirus Disease 2019 (COVID-19).外科口罩分区降低了 2019 冠状病毒病（COVID-19）金黄地鼠模型中非接触传播的风险。
Clin Infect Dis. 2020 Nov 19;71(16):2139-2149. doi: 10.1093/cid/ciaa644.
Zotero 插件